Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the adrenal cancer diagnostics market?

Recent years have seen considerable growth in the size of the adrenal cancer diagnostics market. From $140.35 billion in 2024, it’s expected to escalate to $149.96 billion in 2025 at a Compound Annual Growth Rate (CAGR) of 6.8%. Several factors contributed to this growth during the historical period, including a rise in both incidence and awareness, advancements in genetic and molecular testing, improvements in biopsy techniques, refined endocrine testing, and the integration of artificial intelligence (AI).

What will be the adrenal cancer diagnostics market size in the future?

In the coming years, the adrenal cancer diagnostics market is projected to witness significant growth, with an expected valuation of $193.26 billion by 2029. This implies a compound annual growth rate (CAGR) of 6.5%. The growth during the forecast period can be linked to factors such as the advent of personalized medicine, increasing adoption of minimally invasive procedures, advancements in telemedicine and online consultations, progress in liquid biopsy technology, and broadening genetic counseling services. Key trends during this period are expected to be legislative support for diagnostic innovations, the growing embrace of digital pathology, advancements in imaging techniques, ongoing development in liquid biopsy, and genomic profiling for precision medicine.

Get your adrenal cancer diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

What main drivers are fueling expansion in the adrenal cancer diagnostics market?

An expected surge in cigarette smoking is projected to fuel the progress of the adrenal cancer diagnostics market. This act of consuming cigarettes involves the intake and release of smoke from incinerating tobacco, which possesses nicotine. Nicotine, a habit-inducing alkaloid, can yield both excitatory and calming psychoactive impacts. There’s a conclusive link between cigarette smoking and an amplified risk of developing adrenal cancer forms like adrenal adenomas and adrenocortical carcinomas. Tobacco smoke carcinogens can inflict DNA damage in the adrenal cells, producing mutations that potentially lead to cancer. For instance, data from Statistics Canada in July 2022 reports a 5.8% rise in cigarette production compared to June 2021. Further, the cumulative cigarette sales climbed by 1.3% from May 2022, hitting 1.4 billion in June 2022. Consequently, this increase in cigarette smoking is stimulating the adrenal cancer diagnostics market’s expansion. Efforts initiated by governments in aid of cancer are anticipated to drive the progress of the adrenal cancer diagnostics market. These government-led efforts denote substantial interventions by state authorities to tackle and subdue various problems, challenges or crises. Such initiatives are critical in promoting early cancer diagnosis, enhancing the diagnostic services’ quality and accessibility, aiding research, and thus boosting the adrenal cancer diagnostic tools’ efficiency. For instance, the Biden-Harris administration confirmed an initiative in April 2023, as per the NIH (National Institutes of Health), a U.S. government organization dealing with biomedical and public health research. This initiative aims to reduce cancer-associated fatalities by 50% over the next 25 years and to expand the understanding and support for cancer survivors. As a result, the government’s efforts to aid cancer are propelling the adrenal cancer diagnostics market’s growth.

What key areas define the segmentation of the global adrenal cancer diagnostics market?

The adrenal cancer diagnostics market covered in this report is segmented –

1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy

2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments

3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types

4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI

2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans

3) By X-ray: Standard X-ray Imaging, Specialized X-ray Techniques

4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans

5) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

Who are the dominant players expanding their reach in the adrenal cancer diagnostics market?

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

How are evolving market trends shaping adrenal cancer diagnostics Strategies?

Leading corporations involved in the diagnosis market for adrenal cancer are pioneering new strategies via modern collaboration schematics, an example being the CancerX Startup Accelerator. This initiative aims at enhancing digital revolutions in cancer treatment by providing budding start-ups mentorship, education, and direct contact with key healthcare industry figures, including providers and pharmaceutical manufacturers. In a landmark event in November 2023, CanceRx, LLC, a partnership between public and private sectors in the USA with an aim to propel innovation in battling cancer, announced this initiative at a summit called the Future of Cancer Care in Tampa, Florida. By March 2024, the program plans to select the first batch of 15 to 20 companies, focusing on vital domains, namely clinical examination, screening, diagnosing, and treatment. The initiative, in lining with the Cancer Moonshot agenda, aims to significantly cater to the unfulfilled requirements of cancer care. It is also expected to foster the growth of efficient digital healthcare equipment used in oncology.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242

Which regions are emerging as leaders in the adrenal cancer diagnostics market?

North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cancer Tumor Profiling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Liver Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Lung Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: